Biotech · Private company
Baxalta Innovations GmbH, now part of Shire
Track this companyFree. Adds Baxalta Innovations GmbH, now part of Shire to your Dealase workspace and tells you when its record changes.
Clinical trials140 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials14
- A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)COMPLETED · started May 27, 2022ClinicalTrials.gov NCT05363358 · fetched Nov 12, 2026
- A Study of TAK-881 in Healthy AdultsPHASE1 · COMPLETED · started Oct 12, 2021ClinicalTrials.gov NCT05059977 · fetched Nov 12, 2026
- A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Oct 27, 2020ClinicalTrials.gov NCT04578535 · fetched Nov 12, 2026
- A Study of BAX 888 in Male Adults With Severe Hemophilia APHASE1_PHASE2 · COMPLETED · started Feb 27, 2018ClinicalTrials.gov NCT03370172 · fetched Nov 12, 2026
- rVWF IN PROPHYLAXISPHASE3 · COMPLETED · started Nov 16, 2017ClinicalTrials.gov NCT02973087 · fetched Nov 12, 2026
- Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD SubjectsPHASE3 · COMPLETED · started Sep 25, 2017ClinicalTrials.gov NCT03277313 · fetched Nov 12, 2026
- BAX 802 in CHA With InhibitorsPHASE3 · TERMINATED · started Dec 22, 2016ClinicalTrials.gov NCT02895945 · fetched Nov 12, 2026
- Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life PracticeCOMPLETED · started Dec 14, 2016ClinicalTrials.gov NCT03199794 · fetched Nov 12, 2026
- Stage 1 Study of ARALAST NP and GLASSIA in A1PI DeficiencyPHASE3 · TERMINATED · started Nov 2, 2016ClinicalTrials.gov NCT02722304 · fetched Nov 12, 2026
- Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia ACOMPLETED · started Dec 30, 2015ClinicalTrials.gov NCT02610127 · fetched Nov 12, 2026
- Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQviaCOMPLETED · started Dec 4, 2015ClinicalTrials.gov NCT02556775 · fetched Nov 12, 2026
- BAX 855 PK-guided DosingPHASE3 · COMPLETED · started Nov 23, 2015ClinicalTrials.gov NCT02585960 · fetched Nov 12, 2026
- BAX 855 ContinuationPHASE3 · COMPLETED · started Oct 15, 2013ClinicalTrials.gov NCT01945593 · fetched Nov 12, 2026
- Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic SurgeryPHASE4 · COMPLETED · started May 29, 2006ClinicalTrials.gov NCT00357656 · fetched Nov 12, 2026